{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:47:01Z","timestamp":1778089621792,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcf.2023.11.013","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T03:12:09Z","timestamp":1705806729000},"page":"314-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preventive service utilization among adults with cystic fibrosis covered by private insurance is comparable to the general population"],"prefix":"10.1016","volume":"23","author":[{"given":"Sankalp","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Madison","family":"Hyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djhenne","family":"Dalmacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Don","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Tumin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E","family":"Kirkby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-8992","authenticated-orcid":false,"given":"Seuli","family":"Bose-Brill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-5003","authenticated-orcid":false,"given":"Susan S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.11.013_bib0001","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MCP.0000000000000819","article-title":"Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world - opportunities and challenges","volume":"27","author":"Barry","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2023.11.013_bib0002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1183\/09031936.00196314","article-title":"Future trends in cystic fibrosis demography in 34 European countries","volume":"46","author":"Burgel","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.11.013_bib0003","series-title":"2020 Annual Data Report","article-title":"Cystic Fibrosis Foundation Patient Registry","year":"2021"},{"key":"10.1016\/j.jcf.2023.11.013_bib0004","first-page":"1","article-title":"The changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Modulators","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0005","article-title":"CFTR modulator therapies \u2013 effect on life expectancy in people with cystic fibrosis","author":"Balfour-Lynn","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2023.11.013_bib0006","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.lpm.2017.05.011","article-title":"Current and emerging comorbidities in cystic fibrosis","volume":"46","author":"Ronan","year":"2017","journal-title":"Press Medicale"},{"key":"10.1016\/j.jcf.2023.11.013_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archpedi.153.1.27","article-title":"Preventive services received by adolescents with cystic fibrosis and sickle cell disease","volume":"153","author":"Britto","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jcf.2023.11.013_bib0008","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0197-0070(83)80008-4","article-title":"Adolescents with chronic disease. are they receiving comprehensive health care?","volume":"4","author":"Carroll","year":"1983","journal-title":"J Adolesc Heal Care"},{"key":"10.1016\/j.jcf.2023.11.013_bib0009","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ppul.10342","article-title":"Perspectives of patients with cystic fibrosis on preventive counseling and transition to adult care","volume":"36","author":"Zack","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0010","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S1569-1993(21)01439-9","article-title":"Pregnancy and outcomes in the era of CFTR modulators and COVID-19 pandemic","volume":"20","author":"Li","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.11.013_bib0011","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2017.07.017","article-title":"Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis","volume":"17","author":"Kazmerski","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.11.013_bib0012","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejogrb.2017.12.005","article-title":"High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis","volume":"221","author":"Rousset-Jablonski","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0013","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/humrep\/dev217","article-title":"Contraceptive practices and cervical screening in women with cystic fibrosis","volume":"30","author":"Rousset Jablonski","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jcf.2023.11.013_bib0014","first-page":"1","article-title":"Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study","author":"Archangelidi","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.11.013_bib0015","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic fibrosis colorectal cancer screening consensus recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2023.11.013_bib0016","first-page":"2021","article-title":"Incidence of breast cancer in people with cystic fibrosis: a cause for concern?","author":"FitzMaurice","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.11.013_bib0017","series-title":"MarketScan research database for life sicences researchers","year":"2018"},{"key":"10.1016\/j.jcf.2023.11.013_bib0018","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2023.11.013_bib0019","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1377\/hlthaff.2017.1554","article-title":"Precision medicine in action: the impact of Ivacaftor on cystic fibrosis-related hospitalizations","volume":"37","author":"Feng","year":"2018","journal-title":"Health Aff"},{"key":"10.1016\/j.jcf.2023.11.013_bib0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-0038-1673354","article-title":"Truven health analytics marketscan databases for clinical research in colon and rectal surgery","volume":"32","author":"Kulaylat","year":"2019","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.jcf.2023.11.013_bib0021","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/PPA.S134759","article-title":"Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data","volume":"11","author":"Hamed","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jcf.2023.11.013_bib0022","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.14309\/ajg.0000000000001527","article-title":"Cystic fibrosis transmembrane conductance regulator modulator use is associated with reduced pancreatitis hospitalizations in patients with cystic fibrosis","volume":"116","author":"Ramsey","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0023","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4254\/wjh.v14.i2.411","article-title":"Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis","volume":"14","author":"Ramsey","year":"2022","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0024","series-title":"2019 Annual Data Report","article-title":"Cystic Fibrosis Foundation Patient Registry","year":"2020"},{"key":"10.1016\/j.jcf.2023.11.013_bib0026","first-page":"3","article-title":"Performance-based measures: the early results are in","volume":"13","author":"O'Kane","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jcf.2023.11.013_bib0027","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jadohealth.2018.03.013","article-title":"Increasing delivery of preventive services to adolescents and young adults: does the preventive visit help?","volume":"63","author":"Adams","year":"2018","journal-title":"J Adolesc Heal"},{"key":"10.1016\/j.jcf.2023.11.013_bib0028","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ypmed.2018.08.018","article-title":"Preventive visit among older adults with medicare's introduction of annual wellness visit: closing gaps in underutilization","volume":"115","author":"Chung","year":"2018","journal-title":"Prev Med"},{"key":"10.1016\/j.jcf.2023.11.013_bib0029","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pmedr.2017.12.014","article-title":"Utilization pattern of other preventive services during the US Medicare annual wellness visit","volume":"10","author":"Tao","year":"2018","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.jcf.2023.11.013_bib0030","series-title":"Modern Epidemiology","author":"Rothman","year":"1998"},{"key":"10.1016\/j.jcf.2023.11.013_bib0031","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3748\/wjg.v23.i28.5086","article-title":"Colorectal cancer screening: An updated review of the available options","volume":"23","author":"Issa","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0032","article-title":"Cardiovascular complications in cystic fibrosis: a review of the literature","author":"Poore","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.11.013_bib0033","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcf.2009.09.002","article-title":"Prevalence of dyslipidemia in adults with cystic fibrosis","volume":"9","author":"Rhodes","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.11.013_bib0034","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.amepre.2018.04.028","article-title":"Cervical cancer screening intervals preferred by U.S. women","volume":"55","author":"Cooper","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jcf.2023.11.013_bib0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1513\/AnnalsATS.201911-839OC","article-title":"Patterns of health insurance coverage and lung disease progression in adolescents and young adults with cystic fibrosis","volume":"18","author":"Tumin","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2023.11.013_bib0036","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/MPA.0000000000001815","article-title":"National trends of hospitalizations in cystic fibrosis highlight a need for pediatric to adult transition clinics","volume":"50","author":"Ramsey","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.jcf.2023.11.013_bib0037","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.65.3.567","article-title":"Use of primary care facilities by patients attending specialty clinics","volume":"65","author":"Palfrey","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2023.11.013_bib0038","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-0636","article-title":"Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry","volume":"161","author":"MacKenzie","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2023.11.013_bib0039","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ppul.23227","article-title":"Decline in lung function does not predict future decline in lung function in cystic fibrosis patients","volume":"50","author":"Rosenfeld","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21526","article-title":"Lung function decline from adolescence to young adulthood in cystic fibrosis","volume":"47","author":"Vandenbranden","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0041","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/petr.12401","article-title":"High-risk age window for mortality in children with cystic fibrosis after lung transplantation","volume":"19","author":"Hayes","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jcf.2023.11.013_bib0042","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.125.1_suppl.1S","article-title":"Cystic fibrosis adult care: consensus conference report","volume":"125","author":"Yankaskas","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2023.11.013_bib0043","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1002\/ppul.25745","article-title":"Looking toward the future: approaching care of the aging CF patient","volume":"57","author":"Sala","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0044","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17476348.2019.1552832","article-title":"Acute and chronic non-pulmonary complications in adults with cystic fibrosis","volume":"13","author":"Regard","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jcf.2023.11.013_bib0045","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcf.2020.03.018","article-title":"The specialist as primary care provider in CF","volume":"19","author":"Haywood","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.11.013_bib0046","first-page":"518","article-title":"Adult cystic fibrosis patients\u2019 experiences of primary care consultations: a qualitative study","volume":"56","author":"Lowton","year":"2006","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jcf.2023.11.013_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.27668","article-title":"Challenges and opportunities in the care of survivors of adolescent and young adult cancers","volume":"66","author":"Fidler","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcf.2023.11.013_bib0048","doi-asserted-by":"crossref","first-page":"38","DOI":"10.6004\/jnccn.2017.0005","article-title":"Promoting the shared-care model for adolescent and young adults with cancer: optimizing referrals and care coordination with primary care providers","volume":"15","author":"Kinahan","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.jcf.2023.11.013_bib0049","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11912-020-01011-9","article-title":"Identifying and meeting the needs of adolescents and young adults with cancer","volume":"23","author":"Jin","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jcf.2023.11.013_bib0055","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/crj.12767","article-title":"Health insurance and use of recommended routine care in adults with cystic fibrosis","volume":"12","author":"Li","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jcf.2023.11.013_bib0056","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ppul.23648","article-title":"The effect of the affordable care act dependent coverage provision on patients with cystic fibrosis","volume":"52","author":"Tumin","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.11.013_bib0057","first-page":"P60","article-title":"Health insurance coverage in the United States: 2021","author":"Keisler-Starkey","year":"2022","journal-title":"U S Census Bur"},{"key":"10.1016\/j.jcf.2023.11.013_bib0058","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/pop.2021.0211","article-title":"Short- and long-term health consequences of gaps in health insurance coverage among young adults","volume":"25","author":"Horne","year":"2022","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.jcf.2023.11.013_bib0059","first-page":"215","article-title":"Administrative databases and outcomes assessment: an overview of issues and potential utility","volume":"5","author":"Gandhi","year":"1999","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jcf.2023.11.013_bib0060","article-title":"National center for chronic disease prevention and health promotion, division of population health","year":"2015","journal-title":"BRFSS Prevalence & Trends Data [online]"},{"key":"10.1016\/j.jcf.2023.11.013_bib0050","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American diabetes association and a clinical practice guideline of the cystic fibrosis foundation, endorsed by the pediatric endocrine society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.jcf.2023.11.013_bib0061","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: Executive Summary: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323016983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323016983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:23:24Z","timestamp":1772353404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323016983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1569199323016983"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.11.013","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive service utilization among adults with cystic fibrosis covered by private insurance is comparable to the general population","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}